|
US3009864A
(en)
|
1958-09-18 |
1961-11-21 |
Union Carbide Corp |
Process control
|
|
US3228838A
(en)
|
1959-04-23 |
1966-01-11 |
Union Carbide Corp |
Preservation of biological substances
|
|
US3009861A
(en)
|
1961-01-13 |
1961-11-21 |
Alderton Gordon |
Isolation of bacterial spores
|
|
US3608030A
(en)
|
1969-05-21 |
1971-09-21 |
Howard Tint |
Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
|
|
US4077227A
(en)
|
1976-11-12 |
1978-03-07 |
Regents Of The University Of Minnesota |
Method of freezing liquid material in which agglomeration is inhibited
|
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
|
FI59925C
(fi)
|
1980-01-11 |
1981-11-10 |
Esko Viljo Nurmi |
Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
|
|
US4655047A
(en)
|
1985-03-25 |
1987-04-07 |
I.Q.F. Inc. |
Process for freezing or chilling
|
|
US4839281A
(en)
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
|
DE3887353T2
(de)
|
1987-10-12 |
1994-05-05 |
Capability Services Pty Ltd |
Behandlungsverfahren für magen-darm-krankheiten.
|
|
US5045446A
(en)
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
|
ATE165738T1
(de)
|
1988-08-02 |
1998-05-15 |
Gastro Services Pty Ltd |
Behandlung von gastro-intestinalen krankheiten
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
GB2233343B
(en)
|
1989-06-30 |
1993-07-07 |
Farmos Oy |
A bacterial preparation for use in poultry
|
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5436002A
(en)
|
1991-01-29 |
1995-07-25 |
Mycogen Corporation |
Bacillus thuringiensisisolate PS201T6 toxin
|
|
RU2035186C1
(ru)
|
1992-07-09 |
1995-05-20 |
Семен Рафаилович Резник |
Профилактический биопрепарат споролакт
|
|
EP0671923B1
(en)
|
1992-10-09 |
2001-04-18 |
Advanced Tissue Sciences, Inc. |
Liver reserve cells
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
WO1997008598A1
(de)
|
1995-08-25 |
1997-03-06 |
Gff Technopark |
Verfahren zur simultanen, digitalen phasenempfindlichen detektion von zeitaufgelösten, quasi-gleichzeitig erfassten datenarrays eines periodisch stimulierten systems
|
|
AU7362096A
(en)
|
1995-09-15 |
1997-04-01 |
Dale N. Gerding M.D. |
Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
|
|
AUPO430496A0
(en)
|
1996-12-19 |
1997-01-23 |
Arnott's Biscuits Limited |
Prebiotics and probiotics
|
|
US5965128A
(en)
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
US6589771B1
(en)
|
1999-10-28 |
2003-07-08 |
Immunom Technologies, Inc. |
Methods for arousing dormant bacteria
|
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
US6613549B2
(en)
|
2000-02-10 |
2003-09-02 |
Urex Biotech, Inc. |
Probiotic therapy for newborns
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
JP4410992B2
(ja)
|
2000-11-30 |
2010-02-10 |
ザ バイオ バランス コーポレイション |
細菌株、処理された植物抽出物、それらを含有する組成物、その調製方法、ならびにその治療的応用および産業的応用
|
|
NZ529910A
(en)
|
2001-05-04 |
2007-03-30 |
Univ Florida |
Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
|
|
ITMI20011632A1
(it)
|
2001-07-27 |
2003-01-27 |
Sanofi Synthelabo |
Composizione solida contenente spore di batteri non patogeni del genere bacillus
|
|
GB0130789D0
(en)
|
2001-12-21 |
2002-02-06 |
King S College London |
Application of spores
|
|
US8383342B2
(en)
|
2002-04-24 |
2013-02-26 |
The University Of North Carolina At Greensboro |
Compositions, products, methods and systems to monitor water and other ecosystems
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
AU2002951692A0
(en)
|
2002-09-23 |
2002-10-17 |
Vital Biotech (Hong Kong) Limited |
Improvements in or relating to vaccines
|
|
US20050180962A1
(en)
|
2003-01-30 |
2005-08-18 |
Eyal Raz |
Inactivated probiotic bacteria and methods of use thereof
|
|
US8617870B2
(en)
|
2003-03-13 |
2013-12-31 |
University Of Ottawa |
Antioxidant producing bacterium and uses thereof
|
|
JP4628357B2
(ja)
|
2003-04-23 |
2011-02-09 |
メダレックス インコーポレイテッド |
炎症性腸疾患治療用の組成物及び治療方法
|
|
US20060046246A1
(en)
|
2003-04-24 |
2006-03-02 |
Qiandong Zeng |
Genus, group, species and/or strain specific 16S rDNA sequences
|
|
WO2004104175A2
(en)
|
2003-05-14 |
2004-12-02 |
University Of Georgia Research Foundation, Inc. |
Probiotic bacteria and methods
|
|
RU2006108554A
(ru)
|
2003-08-18 |
2007-09-27 |
Дзе Байо Бэлэнс Корпорейшн (Us) |
Устойчивая жидкая пробиотическая композиция, ее получение и применения
|
|
US20050048515A1
(en)
|
2003-08-29 |
2005-03-03 |
Garner Bryan E. |
Methods for detecting and quantifying specific probiotic microorganisms in animal feed
|
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
CN103039712A
(zh)
|
2004-02-03 |
2013-04-17 |
增值研究合伙有限公司 |
在动物中促进生长的活体细菌的应用
|
|
US7632520B2
(en)
|
2004-02-16 |
2009-12-15 |
Sanjeev Khandelwal |
Synergistic antibacterial formulation and to a method of making the same
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
CA2587670A1
(en)
|
2004-11-01 |
2006-05-11 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
CA2586299C
(en)
|
2004-11-01 |
2014-10-28 |
James W. Stave |
Method for detecting or enriching a target microorganism upon lysis of non-target bacteria with bacteriophage
|
|
US20060188523A1
(en)
|
2005-01-10 |
2006-08-24 |
Zhiheng Pei |
Methods for diagnosing and treating chronic tonsillitis
|
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
AU2006253007B2
(en)
|
2005-05-31 |
2012-12-20 |
Alimentary Health Ltd |
Feline probiotic Bifidobacteria
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
WO2007036230A1
(en)
|
2005-09-28 |
2007-04-05 |
Nordisk Rebalance A/S |
Treatment of ibd and ibs using both probiotic bacteria and fermented cereal as treatment effectors
|
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
WO2007136553A2
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Bacterial strains, compositions including same and probiotic use thereof
|
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
|
WO2007148238A1
(en)
|
2006-06-20 |
2007-12-27 |
Koninklijke Philips Electronics, N.V. |
Electronic capsule for treating gastrointestinal disease
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
EE05459B1
(et)
|
2006-12-08 |
2011-08-15 |
Tartu �likool |
Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
|
|
WO2008076696A2
(en)
|
2006-12-18 |
2008-06-26 |
Washington University In St. Louis |
The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
EA017564B1
(ru)
|
2007-09-12 |
2013-01-30 |
Тарганта Терапьютикс Корп. |
Способ ингибирования клостридиум диффициле введением оритаванцина
|
|
US8236508B2
(en)
|
2008-01-29 |
2012-08-07 |
Drexel University |
Detecting and measuring live pathogens utilizing a mass detection device
|
|
US8021654B2
(en)
|
2008-03-14 |
2011-09-20 |
Danisco A/S |
Methods of treating pigs with Bacillus strains
|
|
CA2720292A1
(en)
|
2008-04-01 |
2009-10-08 |
Metametrix Clinical Laboratory |
Process and method for monitoring gastrointestinal microbiota
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
EP2313773A1
(en)
|
2008-07-15 |
2011-04-27 |
Metanomics Health GmbH |
Means and methods diagnosing gastric bypass and conditions related thereto
|
|
EP2338989A4
(en)
|
2008-08-26 |
2012-06-06 |
Olympus Corp |
METHOD OF PREPARING AN FECAL SAMPLE, PREPARATION SOLUTION OF AN FECAL SAMPLE, AND KIT FOR COLLECTING FECES
|
|
WO2010030997A1
(en)
|
2008-09-12 |
2010-03-18 |
The Washington University |
Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
|
|
US9603876B2
(en)
|
2008-09-25 |
2017-03-28 |
New York University |
Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
|
|
US9340569B2
(en)
|
2008-11-03 |
2016-05-17 |
Tufts University |
Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
IT1393931B1
(it)
|
2009-02-25 |
2012-05-17 |
Neuroscienze Pharmaness S C A R L |
Composizione di spore di batteri non patogeni
|
|
WO2010125421A1
(en)
|
2009-04-30 |
2010-11-04 |
Compagnie Gervais Danone |
Use of collinsella aerofaciens for reducing bloating
|
|
CA2796929C
(en)
|
2009-05-01 |
2020-03-10 |
Micropharma Limited |
Bacterial compositions for prophylaxis and treatment of degenerative disease
|
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
|
US20120264637A1
(en)
|
2009-06-26 |
2012-10-18 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
EP2446062B1
(en)
|
2009-06-26 |
2014-08-13 |
The Regents of the University of California |
Methods and systems for phylogenetic analysis
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
PT2467031E
(pt)
|
2009-08-18 |
2014-10-30 |
Nestec Sa |
Composição nutricional compreendendo estirpes lactococcus e redução de sintomas de alergia, especialmente em bebés e crianças
|
|
WO2011022542A2
(en)
|
2009-08-19 |
2011-02-24 |
Puretech Ventures, Llc |
Administration of factors normally present in a microbial niche to improve health
|
|
WO2011022660A1
(en)
|
2009-08-21 |
2011-02-24 |
Puretech Ventures, Llc |
Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
CA2775050C
(en)
|
2009-09-23 |
2020-07-14 |
Thomas Julius Borody |
Therapy for enteric infections
|
|
CA2776420A1
(en)
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
US20120276149A1
(en)
|
2009-10-15 |
2012-11-01 |
Dan Littman |
Methods for modulating bacterial infection
|
|
AU2010319490B2
(en)
|
2009-11-12 |
2015-03-19 |
Société des Produits Nestlé S.A. |
Nutritional composition for promoting gut microbiota balance and health
|
|
EP2519108A4
(en)
|
2009-12-31 |
2013-10-16 |
Ira Milton Trachtman |
COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF INFLAMMATORY INTESTINAL DISEASE
|
|
ES2623127T3
(es)
|
2010-02-01 |
2017-07-10 |
Mikrobex |
Bacterioterapia para la colitis por Clostridium difficile
|
|
US9492487B2
(en)
|
2010-02-01 |
2016-11-15 |
Matthew Ryan Garner |
Microbial product containing multiple microorganisms
|
|
US20130230498A1
(en)
|
2010-02-16 |
2013-09-05 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
|
|
AU2011223002B2
(en)
|
2010-03-01 |
2015-07-02 |
Institut National De La Recherche Agronomique |
Method of diagnostic of obesity
|
|
CN102939391A
(zh)
|
2010-03-01 |
2013-02-20 |
国家农艺研究院 |
炎症性肠病的诊断方法
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
WO2011113801A1
(en)
|
2010-03-16 |
2011-09-22 |
Universiteit Gent |
Use of clostridium perfringens strain 23 to protect against necrotic enteritis
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
WO2012006369A2
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Immunisation of large mammals with low doses of rna
|
|
EP2593187A4
(en)
|
2010-07-16 |
2014-04-09 |
Univ Arkansas |
METHODS AND COMPOSITIONS COMPRISING SPORTS-CREATING BACTERIA FOR ENHANCING ANIMAL HEALTH
|
|
FI20105825A
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
|
WO2012016287A2
(en)
|
2010-08-04 |
2012-02-09 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for deuvering them
|
|
US9386793B2
(en)
|
2010-08-20 |
2016-07-12 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
AU2011299285B2
(en)
|
2010-09-10 |
2017-01-05 |
Ntcd, Llc |
Environmental Clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
|
WO2012045150A1
(en)
|
2010-10-04 |
2012-04-12 |
British Columbia Cancer Agency Branch |
Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
|
|
EP2662078A1
(en)
|
2010-11-10 |
2013-11-13 |
National Jewish Health |
Methods to Treat Allergic Conditions
|
|
US20120064592A1
(en)
|
2011-01-26 |
2012-03-15 |
Qteros, Inc. |
Biocatalysts synthesizing deregulated cellulases
|
|
US8927252B2
(en)
|
2011-02-09 |
2015-01-06 |
Lavivo Ab |
Synbiotic compositions for restoration and reconstitution of gut microbiota
|
|
AR085409A1
(es)
|
2011-02-25 |
2013-10-02 |
Tricorder Diagnostics Llc |
Firmas microbianas como indicadores de exposicon a radiacion
|
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
|
EP4129312A1
(en)
|
2011-03-09 |
2023-02-08 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
US20120276056A1
(en)
|
2011-04-26 |
2012-11-01 |
Wieslaw Janusz Bochenek |
Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
|
|
US20140179726A1
(en)
|
2011-05-19 |
2014-06-26 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
|
US9579353B2
(en)
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
|
US20130017999A1
(en)
|
2011-07-14 |
2013-01-17 |
Marc Fremont |
Methods and Compositions for Evaluating and/or Treating Chronic Immune Diseases
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
CA2843388A1
(en)
|
2011-07-27 |
2013-01-31 |
Max International, Llc |
Compositions comprising sugar-cysteine products
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
BR112014004890A8
(pt)
|
2011-08-30 |
2018-02-06 |
Acad Medisch Ct |
Bactéria, composição farmacêutica, alimentícia ou de ração, e, uso da bactéria
|
|
ES2662793T3
(es)
|
2011-09-14 |
2018-04-09 |
Nubiyota Llc |
Complementos de medio y métodos para cultivar microorganismos anaerobios gastrointestinales humanos
|
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
|
US20130115232A1
(en)
|
2011-10-03 |
2013-05-09 |
Fred Hutchinson Cancer Research Center |
Methods for detecting graft-versus-host disease
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
CA2850437A1
(en)
|
2011-10-11 |
2013-04-18 |
Achim Biotherapeutics Ab |
Composition comprising anaerobically cultivated human intestinal microbiota
|
|
JP6306507B2
(ja)
|
2011-12-01 |
2018-04-18 |
国立大学法人 東京大学 |
制御性ｔ細胞の増殖または集積を誘導するヒト由来細菌
|
|
GB201201766D0
(en)
|
2012-02-01 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
|
US20150125883A1
(en)
|
2012-04-30 |
2015-05-07 |
Washington University |
Method of isolating and characterizing microorganisms that are targets of host immune responses
|
|
EP2850202B1
(en)
|
2012-05-18 |
2020-03-11 |
Genome Research Limited |
Methods and groups
|
|
DK2854850T3
(da)
|
2012-05-25 |
2021-08-30 |
Sloan Kettering Inst Cancer Res |
Sammensætninger til behandling eller forebyggelse af strålingssygdom og gi-syndrom
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
EP2684469A1
(en)
|
2012-07-13 |
2014-01-15 |
Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO |
Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
KR102617655B1
(ko)
|
2012-11-23 |
2023-12-27 |
세레스 테라퓨틱스, 인코포레이티드 |
상승작용적 박테리아 조성물, 그리고 이의 제조 방법 및 용도
|
|
JP2016509003A
(ja)
|
2013-02-04 |
2016-03-24 |
セレス セラピューティクス インコーポレイテッド |
組成物および方法
|
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
|
WO2014153194A2
(en)
|
2013-03-14 |
2014-09-25 |
Seres Health, Inc. |
Methods for pathogen detection and enrichment from materials and compositions
|
|
WO2014145958A2
(en)
|
2013-03-15 |
2014-09-18 |
Seres Health, Inc. |
Network-based microbial compositions and methods
|
|
EP2991659B1
(en)
|
2013-05-03 |
2018-10-10 |
Nestec S.A. |
Lachnospiraceae in the gut microbiota and association with body weight
|
|
WO2015019976A1
(ja)
*
|
2013-08-05 |
2015-02-12 |
第一三共株式会社 |
肝障害のタイプの検査方法
|
|
WO2015018308A1
(en)
|
2013-08-06 |
2015-02-12 |
BGI Shenzhen Co.,Limited |
Biomarkers for colorectal cancer
|
|
KR102515850B1
(ko)
|
2013-11-25 |
2023-03-30 |
세레스 테라퓨틱스, 인코포레이티드 |
상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
|
|
WO2015095241A2
(en)
|
2013-12-16 |
2015-06-25 |
Seres Health, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
AU2016359178A1
(en)
|
2015-11-24 |
2018-06-14 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
|
ES2962302T3
(es)
|
2015-12-14 |
2024-03-18 |
Metabogen Ab |
Tratamiento de la colestasis intrahepática y hepatopatías relacionadas
|
|
AU2017234120B2
(en)
|
2016-03-14 |
2024-06-20 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
KR20240110077A
(ko)
|
2017-08-14 |
2024-07-12 |
세레스 테라퓨틱스, 인코포레이티드 |
담즙정체성 질환 치료를 위한 조성물 및 방법
|
|
CA3077692A1
(en)
|
2017-10-03 |
2019-04-11 |
Seres Therapeutics, Inc. |
Manipulation of tryptamine metabolism
|
|
BR112020008552A2
(pt)
|
2017-10-30 |
2020-12-29 |
Seres Therapeutics, Inc. |
métodos e composições para tratamento de resistência a antibiótico
|
|
WO2019191694A1
(en)
|
2018-03-29 |
2019-10-03 |
Seres Therapeutics, Inc. |
Compositions and methods for treating inflammatory bowel diseases
|
|
MX2020012602A
(es)
|
2018-05-24 |
2021-03-31 |
Seres Therapeutics Inc |
Composiciones bacterianas dise?adas y usos de las mismas.
|